Genmab — November 2020

[Solsen]

We dont need discuss the issue

[E_L]

lol. there may have been many more things, but unfortunately nobody could understand Judith

[Solsen]

I still belive in what I wrote. Next week perhaps hardcore data could help me...

[Sukkeralf]

E L 2 new antibodies - is it the Janssen one and hexaCD38 or have I missed something?

[E_L]

17:25 and 17:32 yesterday, 1 JNJ, 1 Amgen

[E_L]

Oral Cami at ASH - 474 Preliminary Results of a Phase 2 Study of Camidanlumab Tesirine (Cami), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Hodgkin Lymphoma - https://ash.confex.com/ash/2020/webprogram/Paper137451.html

[E_L]

ADCT have 6 abstracts on Cami...

[Sukkeralf]

E L - okay so old antobody in two new trials

[SEACOP]

Danske Bank 5/11: "Valuation and estimate changes. Our updated SoTP points to a fair value of DKK2,467 (DKK2,306) per share. Adjustments reflect higher estimates/value for Tepezza, epocoritamab and GEN1046. We still include 50% probability of losing the daratumumab arbitrage dispute, which would have ~DKK200/share impact."

[E_L]

the JNJ is new isn't it? (and to me the other one as well
)

[E_L]

not sure what the JNJ is targeting; we have the other one for prostate cancer that is PSMAxCD3

[E_L]

JNJ's list of ASH
abstracts https://www.janssen.com/janssen-headlines-american-society-hematology-annual-meeting-more-35-presentations-highlighting-deep

[Sukkeralf]

Its targeting CD3 at least - but what target on the cancer cell I could not find

[deleted-user]

Mon vi får +20 i luk igen i
dag?

[deleted-user]

15 kr. og 62.000 aktier. Tror også det bliver grønt igen i morgen, hvis ellers ikke US vælter i løbet af natten

[Helge_LarsenPI-redaktør]

2592..Flot

[Skyggen]

Det er først imorgen Helge idag tager vi til takke med 2492

[Legolas23]

Arrhhh 2494

[Legolas23]

2492

[Legolas23]

Flot luk og godkendt dag